HCW Biologics Inc.
HCWB
$7.05
-$0.58-7.60%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -7.41% | -31.10% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -7.41% | -31.10% | |||
| Cost of Revenue | -7.42% | -22.19% | |||
| Gross Profit | -7.39% | -52.72% | |||
| SG&A Expenses | 34.45% | -78.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 17.92% | -71.52% | |||
| Operating Income | -20.86% | 73.33% | |||
| Income Before Tax | 13.56% | 74.46% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 13.56% | 74.46% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 13.56% | 74.46% | |||
| EBIT | -20.86% | 73.33% | |||
| EBITDA | -6.05% | 74.01% | |||
| EPS Basic | 22.71% | 74.46% | |||
| Normalized Basic EPS | -7.08% | 72.08% | |||
| EPS Diluted | 22.71% | 74.46% | |||
| Normalized Diluted EPS | -7.08% | 72.08% | |||
| Average Basic Shares Outstanding | 11.83% | 0.00% | |||
| Average Diluted Shares Outstanding | 11.83% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||